Review: Link for Physical Activity, Atopic Dermatitis Unclear

This article originally appeared here.
Share this content:
Review: Link for Physical Activity, Atopic Dermatitis Unclear
Review: Link for Physical Activity, Atopic Dermatitis Unclear

FRIDAY, Sept. 25, 2015 (HealthDay News) -- The correlation between physical activity and atopic dermatitis (AD) is unclear, according to a research letter published online Sept. 19 in the British Journal of Dermatology.

A. Kim, and Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the Northwestern University Feinberg School of Medicine in Chicago, conducted a systematic review of the literature and a meta-analysis to examine the correlation between AD and vigorous physical activity. Seven articles with eight studies were included in the final analysis; five of these were included in the meta-analysis.

The researchers observed a positive correlation between AD and physical activity in three studies, an inverse correlation in three studies, and no correlation in one study. There were no studies of the correlation between exercise or physical activity and eczema severity. In a meta-analysis of four studies with 61,974 patients, 8.7, 8.8, and 23.8 percent of those with less than once weekly exercise, at least once weekly exercise, and at least three times weekly exercise, respectively, had a history of AD. In random-effects models, neither vigorous physical activity nor exercise at least once or three times weekly was associated with AD.

"Future studies are needed to address the knowledge gaps about the association of AD and physical activity," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »